LAUREN KILEY: Open Payments
NPI 1497288765 · ROBBINSVILLE, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$487 in 24 payments from 22 companies in 2025. Trend: 2023 $233 · 2024 $566 · 2025 $487
Food & beverage: $487
| Company | Payments | Amount |
|---|---|---|
| Caris MPI, Inc. | 1 | $45 |
| Myriad Genetic Laboratories, Inc. | 1 | $38 |
| Gilead Sciences, Inc. | 2 | $31 |
| ABBVIE INC. | 2 | $30 |
| Aveo Pharmaceuticals, Inc. | 1 | $27 |
| GENZYME CORPORATION | 1 | $25 |
| Genmab U.S., Inc. | 1 | $23 |
| Pharmacosmos Therapeutics Inc. | 1 | $22 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $22 |
| Incyte Corporation | 1 | $20 |
Products named: MI CANCER SEEK, EPKINLY, MYRISK, Trodelvy, FOTIVDA, CERDELGA, MONOFERRIC, Nubeqa.
Industry payments across NJ — which companies pay providers there.
